In vitro protoscolicidal effects of fungal chitosan isolated from Penicillium waksmanii and Penicillium citrinum
Hydatidosis is caused by a tapeworm which infects humans by the larval stage. In humans, the disease is so serious that it requires surgery for treatment. Documents show that there have been many efforts in finding new scolicidal agents for reducing the rate of the infection. The objective of this study was determination of the scolicidal effect of two fungal chitosan types, produced from Penicillium spp. and commercially chitosan (CC) on Echinococcus granulosus protoscolex. Protoscolices were aseptically aspirated from sheep livers hydatid cysts. Four concentrations (50, 100, 200, 400 μg/ml) of each type of prepared chitosan were used for 10, 30, 60 and 180 min. Viability of protoscolices was detected by 0.1 % eosin staining. Fungal chitosan which was the most bioactive type with higher degree of deacetylation showed stronger scolicidal activity in vitro (P < 0.05). Fungal chitosan could be recommended, as good as CC for hydatid cysts control and is a noble alternative for synthetic and chemical scolicidal.
KeywordsChitosan Protoscolices Echinococcus granulosus Penicillium
The authors would like to appreciate Dr. Mohammad Ali Ebrahimzadeh for his precious directions. This work was supported by a Grant from Student Research Committee of Mazandaran University of Medical Sciences, Sari, Iran.
- Jeihanipour A, Karimi K, Taherzadeh MJ (2007) Antimicrobial properties of fungal chitosan. Res J Biol Sci 2(3):239–243Google Scholar
- Li X-F, Feng X-Q, Yang S, Wang T-P, Su Z-X (2008) Effects of molecular weight and concentration of chitosan on antifungal activity against Aspergillus niger. Iran Polym J 17(11):843–852Google Scholar
- Seyfarth F, Schliemann S, Elsner P, Hipler UC (2008) Antifungal effect of high- and low-molecular-weight chitosan hydrochloride, carboxymethyl chitosan, chitosan oligosaccharide and N-acetyl-d-glucosamine against Candida albicans, Candida krusei and Candida glabrata. Int J Pharm 353:139–148PubMedGoogle Scholar
- Singh MK, Prajapati SK, Mahor A, Rajput N, Singh R (2011) Chitosan: a novel exepient in pharmaceutical formulation. Int J Pharm Sci Res 2(9):2266–2277Google Scholar
- Tipparat H, Oraphan R (2008) Effect of deacetylation conditions on antimicrobial activity of chitosans prepared from carapace of black tiger shrimp (Penaeusmonodon). J Sci Technol 30:1–9Google Scholar